Status: Current Private

Ellie Diagnostics

Disruptive animal health provider delivering innovative diagnostic solutions to veterinarians and pet owners across the United States.

Antios Therapeutics

Clinical-stage biotechnology company developing innovative therapies to treat and cure chronic hepatitis B virus (HBV).

Ribon Therapeutics

Clinical-stage biotechnology company pursuing the development of novel small molecules that target cancer through its dependency on stress support pathways.

Arch Oncology

Clinical-stage immuno-oncology company that aims to discover and develop potential best-in-class antibody therapies for the treatment of patients with cancer.

Amber Ophthalmics

Clinical-stage ophthalmic company focused on novel therapeutics to address unmet medical needs, providing for the restoration, preservation, and improvement of patient vision and quality of life.

Sebela Pharmaceuticals

Commercial-stage specialty pharmaceutical company focused on gastrointestinal, dermatological, and women’s health products.

Saol Therapeutics

Commercial-stage specialty pharmaceutical company focused on the central nervous system (CNS), orphan diseases, and conditions with high unmet medical need.